Status:
WITHDRAWN
Genome-wide Association Study
Lead Sponsor:
Samsung Medical Center
Conditions:
Esophageal Squamous Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
To explore biomarkers predictive of clinical response to Taxane/5-FU/platinum based chemotherapy in esophageal squamous cell carcinoma. To identify negative predictive markers to 5-FU/platinum/Taxane....
Eligibility Criteria
Inclusion
- Histological confirmed esophageal squamous cell carcinoma
- Patients treated with Taxane or 5-FU or platinum based chemotherapy.
- provision of a signed written informed consent.
Exclusion
- patients not signed written informed consent.
- patient unacceptable for study in the judgement of the investigator.
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 3 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01498757
Start Date
January 1 2012
End Date
July 3 2012
Last Update
May 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung medical Center
Seoul, South Korea